Lenzing's €301 Million Refinancing Is Done — Now Comes the Hard Part
Published on 10/22/2026 at 10:31 | Editorial boerse-global.de
Lenzing has closed the books on its rights issue, pulling in a gross EUR 301.2 million and nearly doubling its share count in one stroke. What the Austrian fibre maker has not yet done is prove that the money will earn its keep.
The transaction wrapped with a 99% take-up from existing shareholders, leaving the syndicate banks to sell only a sliver on the market. That final placement closes out the preliminary subscription result reported on Tuesday — there is no leftover stock still hunting for buyers. B&C Group and Suzano between them picked up roughly 52.25% of the offer, with Oberbank also participating, a show of support that carried much of the financing.
The Price of the Cash
The capital came at a cost measured in paper. Lenzing issued 34,756,362 new shares at EUR 8.65 apiece, and with the announced extension of the listing the total share count now stands at 73,374,542 — a base more than twice its former size.
That dilution is the other face of the same coin. Reuters flagged the deeply discounted rights issue as the concrete trigger behind the sharp share-price move in early October, and the completed placement and that earlier dilution pressure simply describe two sides of one transaction. Tuesday's 2.6% decline, meanwhile, cannot be pinned cleanly on the financing either way — a single day's move answers neither the question of what the capital buys nor whether the strategy behind it will work.
Should investors sell immediately? Or is it worth buying Lenzing?
Where the Money Is Headed
Management intends to channel the proceeds into its "Grow Nonwovens, Reset Textiles" strategy while shoring up the balance sheet. Those are two distinct purposes, and investors would do well to keep them apart: the cash inflow is a certainty, whereas the economic payoff from the measures it funds has yet to surface in the business. Closing a financing is not the same as completing a turnaround.
The strong subscription rate supports the optimistic reading — but only as a starting point. It reflects a willingness to commit at the offer price, not a verdict on how the new shares will trade once they hit the floor. Subscribing and subsequent price performance are separate tests, and the heavy participation of B&C and Suzano says nothing on its own about the returns those shares will deliver.
A Date With a Condition Attached
Delivery and the start of trading in the new shares on the Prime Market of the Vienna Stock Exchange are scheduled for 23 October. Both remain conditional on the capital increase being entered in the commercial register, and the Vienna Stock Exchange has announced the corresponding expansion of the listing.
Until that registration clears, the strengthened capital structure can lend support to the bullish case for as long as confidence in an effective deployment of the funds holds up. Should that confidence fray, the dilution is likely to weigh more heavily. The 23 October debut is the next fixed item on the calendar; the longer-term investment case, though, will hinge on whether Lenzing turns the proceeds into visible progress on its strategy — and on whether the enlarged share base ends up matched by a commensurate economic return.
Ad
Lenzing Stock: New Analysis - 22 October
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
